MORIMATSU INTL Stock Forum

Morimatsu recently supplied bioreactors to NIBRT in Ireland, supporting advanced research in the field of biomedicine.
Ireland's strategic location, abundant talent pool, and robust research infrastructure make it an ideal environment for the growth of the biopharmaceutical industry. These advantages have attracted global companies,...

Please enter the link to register. The Forum Agenda will become available very soon.
Seats are limited due to venue capacity, and will be allocated on a first-come, first-served basis.
Be sure to secure your spot early!
About Morimatsu Energy & Materials
As a key division of Morimatsu International Holdings Company Limited (Stock Code: 2155.HK),[Morimatsu Energy & Materials]remain focu...

As emerging technologies continue to advance, the food industry is undergoing disruptive transformations. One of the most notable examples is cultured meat, which has garnered global attention for its innovative and environmentally sustainable features.
Cultured meat, a meat alternative produced through technological means, essentially represents a more controlled industrial production process. It ...

Microfluidic Technology is an interdisciplinary technology that has recently achieved notable progress in fields such as biomedicine, cosmetics, and biopesticides. It shows significant potential for application, with the promise of driving the development and upgrading of related industries.
What is Microfluidic Preparation Technology?
Microfluidic preparation technology, based on microfluidic chip ch...

In the current pharmaceutical field, the market share for cell and antibody therapies is steadily increasing. These therapies hold great promise for patient benefit and medical progress, and are rapidly emerging as effective solutions to complex diseases. As the demand for these cutting-edge drugs grows, it has become a critical challenge to achieve efficient and stable large-scale production. In this process, bi...

MORIMATSU OPEN DAY
Seminar on Approaching Morimatsu
Integrated Innovation, Stepping into the Future
On October 17, the "Integrated Innovation, Stepping into the Future" - 2024 Seminar on Approaching Morimatsu was held by Morimatsu LifeSciences in Changshu Manufacturing Base.
Highlights
At this conference, invited industry experts shared their experience with Morimatsu experts. Professionals from the...

On 14th October 2024, a delivery ceremony for the Singapore modular plant project, a collaboration between WuXi XDC and Pharmadule Morimatsu, was held at the Morimatsu Changshu Plant. The partnership has led to the successful delivery of state-of-the-art modular production facilities, including the first batch of nearly 100 modules, to WuXi XDC's Singapore manufac...

Upcoming Conferences
ISPE Annual Meeting&Expo 2024
The ISPE Annual Meeting & Expo 2024 is a must-attend pharmaceutical industry gathering that provides an unparalleled platform for key industry discussions. This event is where emerging talents and seasoned experts from pharmaceutical manufacturing, supply chain, devices, services, and global regulatory agencies come together to share and discuss the latest advancemen...

Morimatsu (Jiangsu) Heavy Industry Co., Ltd. and PGT (a fine chemicals production company) signed a Letter of Intent on September 23, 2024 at the headquarters of PGT in Seoul, South Korea, to jointly develop a production unit with an annual output of 15,000 tons of LiPF6 (modular delivery) at a time when the inves...

Upcoming Conferences
ISPE Boston Product Show 2024
The ISPE Boston Product Show is the first-class show in the Northeast United States for the biopharmaceutical industry, as well as the flagship event of ISPE Boston Chapter. The event will bring together more than 4,200 biopharmaceutical professionals to share knowledge of breakthrough technologies and regulations in the industry.
Date
October 2
Venue
Gillett...